OrbiMed’s Acutus Medical Inc AFIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,648,386
Closed -$498K 126
2024
Q1
$498K Hold
2,648,386
0.01% 111
2023
Q4
$535K Hold
2,648,386
0.01% 109
2023
Q3
$1.84M Hold
2,648,386
0.04% 113
2023
Q2
$2.35M Hold
2,648,386
0.04% 114
2023
Q1
$2M Hold
2,648,386
0.04% 113
2022
Q4
$3.05M Hold
2,648,386
0.06% 99
2022
Q3
$2.33M Hold
2,648,386
0.04% 120
2022
Q2
$2.97M Hold
2,648,386
0.05% 123
2022
Q1
$3.68M Hold
2,648,386
0.06% 126
2021
Q4
$9.03M Hold
2,648,386
0.12% 119
2021
Q3
$23.4M Sell
2,648,386
-2,829,572
-52% -$37.2M 0.26% 89
2021
Q2
$93M Hold
5,477,958
0.94% 33
2021
Q1
$73.2M Hold
5,477,958
0.68% 45
2020
Q4
$158M Hold
5,477,958
1.38% 18
2020
Q3
$163M Buy
+5,477,958
New +$166M 2.05% 14

Other funds holding AFIB

OrbiMed's AFIB Position: Q2 2024 in Review

OrbiMed sold out of Acutus Medical Inc (AFIB) in Q2 2024, closing a stake of 2,648,386 shares — an estimated $498K sold.

OrbiMed first reported a position in AFIB in Q3 2020 and held it in 15 quarters. The position peaked at $163M in Q3 2020. 1 fund tracked by Wall St. Rank holds AFIB as of Q2 2024.

  • OrbiMed reported no remaining Acutus Medical Inc position as of Q2 2024 after selling out during the quarter.
  • OrbiMed sold 2,648,386 Acutus Medical Inc shares in Q2 2024, an estimated $498K.
  • OrbiMed first reported a position in Acutus Medical Inc in Q3 2020 and held it in 15 quarters.
  • OrbiMed's Acutus Medical Inc position peaked at $163M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Acutus Medical Inc as of Q2 2024.

Based on OrbiMed's 13F filing for Q2 2024, filed 14 Aug 2024.